Scientists Scan for Weaknesses in the SARS-CoV-2 Spike Protein

The virus’s tool for prying open host cells is coated in a protective armor of sugar—but gaps may offer vulnerability to disruption by antibodies.

Written byChris Baraniuk
| 5 min read
coronavirus sars-cov-2 spike protein covid-19 structure glycans ace2 furin antibody

Register for free to listen to this article
Listen with Speechify
0:00
5:00
Share

ABOVE: © ISTOCK.COM, TRAFFIC_ANALYZER

Coronaviruses’ visual hallmarks, those nubby protrusions sticking out in every direction, are the keys they use to enter cells. These so-called spike proteins bind to cells—in the case of SARS-CoV-2, human cells—to launch infection. To prevent that from happening, scientists around the world are focusing on the spike to reveal how it works, and find potential weaknesses to exploit.

The spike structure itself is actually made up of three proteins. At the top lies the point at which the viral particle grasps an enzyme on the surface of human cells known as the ACE2 receptor.

This point must be in an “open” or “up” position, flexed and ready to attach itself to the host cell receptor, says Rommie Amaro, a biophysical chemist at the University of California, San Diego. An animation posted online by Greg Bowman, a biophysicist at Washington University School of Medicine, reveals that ...

Interested in reading more?

Become a Member of

The Scientist Logo
Receive full access to more than 35 years of archives, as well as TS Digest, digital editions of The Scientist, feature stories, and much more!
Already a member? Login Here

Related Topics

Meet the Author

  • chris baraniuk

    Chris Baraniuk is a freelance science journalist based in Northern Ireland who contributes to The Scientist. He has covered biological and medical science for a range of publications, including the BBC, the BMJ, and Mosaic. He also writes about nature, climate change, and technology. His background in the humanities has long proved invaluable in his quest to bring science stories to people from all walks of life.

    View Full Profile
Share
Image of a man in a laboratory looking frustrated with his failed experiment.
February 2026

A Stubborn Gene, a Failed Experiment, and a New Path

When experiments refuse to cooperate, you try again and again. For Rafael Najmanovich, the setbacks ultimately pushed him in a new direction.

View this Issue
Human-Relevant In Vitro Models Enable Predictive Drug Discovery

Advancing Drug Discovery with Complex Human In Vitro Models

Stemcell Technologies
Redefining Immunology Through Advanced Technologies

Redefining Immunology Through Advanced Technologies

Ensuring Regulatory Compliance in AAV Manufacturing with Analytical Ultracentrifugation

Ensuring Regulatory Compliance in AAV Manufacturing with Analytical Ultracentrifugation

Beckman Coulter logo
Conceptual multicolored vector image of cancer research, depicting various biomedical approaches to cancer therapy

Maximizing Cancer Research Model Systems

bioxcell

Products

Sino Biological Logo

Sino Biological Pioneers Life Sciences Innovation with High-Quality Bioreagents on Inside Business Today with Bill and Guiliana Rancic

Sino Biological Logo

Sino Biological Expands Research Reagent Portfolio to Support Global Nipah Virus Vaccine and Diagnostic Development

Beckman Coulter

Beckman Coulter Life Sciences Partners with Automata to Accelerate AI-Ready Laboratory Automation

Refeyn logo

Refeyn named in the Sunday Times 100 Tech list of the UK’s fastest-growing technology companies